Four years ago, presentations on health care innovation were few and far between at South by Southwest (SXSW). Fast forward to today: health innovations reign supreme at the famous Austin conference, with over 30 presentations dedicated to discussing revolutionary ideas that will collaboratively transform the dialogue between patients, policy makers, physicians, and other health stakeholders.
Thanks to Medicare Part D, many seniors are now able to spend more quality time with their families and less time in hospital rooms. A new study, conducted by Johns Hopkins Bloomberg School of Public Health and the University of Chicago, shows that expansion of prescription coverage under Part D has reduced hospital admissions by 8%.
March marks the beginning of spring, but this year it also marks an ending: the health insurance marketplaces set up by the Affordable Care Act (ACA) close for enrollment on March 31st.
Happy Rare Disease Day! While a disease may be rare, each story is one of many. In fact, when taken together, rare diseases affect 30 million Americans.
In the spirit of this year's Rare Disease Day theme, "Join Together for Better Care," today's Lone Star Links focus on the organizations in Texas and across the country that are working together in the fight for rare diseases.
Medicare Part D has helped thousands in the Evergreen state gain access to innovative new treatments over the last 10 years. A new op-ed written by BJ Cavnor, executive director of One in Four Chronic Health, urges policymakers to make sure Washingtonians continue to benefit from this successful program. Of course, Medicare Part D isn't just helping the residents of Washington. Part D enables people all across the country to live longer, healthier lives. As a result of Part D, 90% of American seniors have comprehensive prescription coverage that provides access the medications they need.
This Friday marks Rare Disease Day, a celebration of the over 300 million people--including 25 to 30 million Americans--who live with a rare disease. Rare Disease Day not only raises awareness about lesser-known illnesses; it also empowers patients, policymakers, and pharmaceutical companies to take action.
One in nine. That's the number of people over 65 in the Lone Star State who've been diagnosed with Alzheimer's. They're part of the 340,000 Texans with Alzheimer's, a number expected to grow exponentially by 2050. Across the country, Alzheimer's care costs families and taxpayers about $183 billion annually, creating a difficult burden for families already dealing with the emotional toll of the disease.
Did you know that nearly one in ten Americans live with a rare disease? In the U.S., a rare disease is defined as a condition that affects fewer than 200,000 people. Over 7,000 rare diseases have been identified so far, and each poses unique questions and challenges to companies and researchers looking for a cure.
Good news from the FDA: for the first time since 2006, the number of new drug shortages has decreased. The reduction is due in part to the Prescription Drug User Fee Act (PDUFA V), passed as part of the Food and Drug Safety and Innovation Act (FDASIA) last July. The bill provided the FDA with "important new authorities and responsibilities to help prevent and mitigate drug shortages," stated Congressman Fred Upton at a recent meeting of the Energy and Commerce Committee.
This week, a reported 89,500 more Texans signed up for an insurance plan through the federal health insurance marketplace, bringing the total to 207,500. As thousands of Texans gain coverage through the Affordable Care Act, access to previously unavailable mental health services could improve the quality of life for those living with a mental health condition.